Camarda Financial Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-17,980
Closed -$2.17M 233
2018
Q3
$2.17M Sell
17,980
-345
-2% -$42.8K 2.46% 7
2018
Q2
$2.11M Sell
18,325
-2,286
-11% -$250K 2.22% 6
2018
Q1
$1.77M Sell
20,611
-4,016
-16% -$311K 1.83% 8
2017
Q4
$1.82M Sell
24,627
-2,768
-10% -$185K 2.18% 6
2017
Q3
$1.58M Buy
+27,395
New +$1.62M 1.7% 17
2015
Q3
Sell
-21,586
Closed -$1.48M 210
2015
Q2
$1.48M Buy
21,586
+3,466
+19% +$220K 0.82% 39
2015
Q1
$1.01M Buy
18,120
+218
+1% +$11.2K 0.56% 51
2014
Q4
$918K Buy
17,902
+6,322
+55% +$310K 0.58% 48
2014
Q3
$426K Buy
11,580
+1,508
+15% +$54.4K 0.3% 55
2014
Q2
$394K Sell
10,072
-2,366
-19% -$87.8K 0.27% 63
2014
Q1
$469K Sell
12,438
-1,398
-10% -$48.8K 0.36% 59
2013
Q4
$523K Buy
+13,836
New +$529K 0.43% 57
2013
Q3
Sell
-10,294
Closed -$373K 237
2013
Q2
$373K Buy
+10,294
New +$313K 0.34% 46

Other funds holding USNA

Camarda Financial Advisors's USNA Position: Q4 2018 in Review

Camarda Financial Advisors sold out of Usana Health Sciences (USNA) in Q4 2018, closing a stake of 17,980 shares — an estimated $2.17M sold.

Camarda Financial Advisors first reported a position in USNA in Q2 2013 and held it in 13 quarters. The position peaked at $2.17M in Q3 2018. 190 funds tracked by Wall St. Rank hold USNA as of Q4 2018.

  • Camarda Financial Advisors reported no remaining Usana Health Sciences position as of Q4 2018 after selling out during the quarter.
  • Camarda Financial Advisors sold 17,980 Usana Health Sciences shares in Q4 2018, an estimated $2.17M.
  • Camarda Financial Advisors first reported a position in Usana Health Sciences in Q2 2013 and held it in 13 quarters.
  • Camarda Financial Advisors's Usana Health Sciences position peaked at $2.17M in Q3 2018.
  • 190 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2018.

Based on Camarda Financial Advisors's 13F filing for Q4 2018, filed 23 Jan 2019.